These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11744067)

  • 1. Is nitric oxide overproduction the target of choice for the management of septic shock?
    Feihl F; Waeber B; Liaudet L
    Pharmacol Ther; 2001 Sep; 91(3):179-213. PubMed ID: 11744067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide in sepsis-syndrome: potential treatment of septic shock by nitric oxide synthase antagonists.
    Ketteler M; Cetto C; Kirdorf M; Jeschke GS; Schäfer JH; Distler A
    Kidney Int Suppl; 1998 Feb; 64():S27-30. PubMed ID: 9475485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide and septic shock.
    Cobb JP; Danner RL
    JAMA; 1996 Apr; 275(15):1192-6. PubMed ID: 8609688
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock.
    Iskit AB; Guc O
    Acta Pharmacol Sin; 2003 Oct; 24(10):953-7. PubMed ID: 14531935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid.
    Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Schunck WH; Falck JR; Malik KU
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(2):121-50. PubMed ID: 23013331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock.
    Wolfe TA; Dasta JF
    Ann Pharmacother; 1995 Jan; 29(1):36-46. PubMed ID: 7536056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies.
    Kilbourn RG; Szabó C; Traber DL
    Shock; 1997 Apr; 7(4):235-46. PubMed ID: 9110408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Septic shock and nitric oxide].
    Lorente JA; Delgado MA; Landín L
    Enferm Infecc Microbiol Clin; 1997 Oct; 15 Suppl 3():14-9. PubMed ID: 9410077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and cardiovascular effects of nitric oxide modulation in the therapy of septic shock.
    Schoonover LL; Stewart AS; Clifton GD
    Pharmacotherapy; 2000 Oct; 20(10):1184-97. PubMed ID: 11034042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence.
    Escames G; Acuña-Castroviejo D; López LC; Tan DX; Maldonado MD; Sánchez-Hidalgo M; León J; Reiter RJ
    J Pharm Pharmacol; 2006 Sep; 58(9):1153-65. PubMed ID: 16945173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nitric oxide--an important mediator in sepsis?].
    Kirkebøen KA; Strand OA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4061-5. PubMed ID: 10613098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide and septic shock. From bench to bedside.
    Kuhl SJ; Rosen H
    West J Med; 1998 Mar; 168(3):176-81. PubMed ID: 9549416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yet another potential role for nitric oxide in the pathophysiology of septic shock.
    Sheehan M; Wong HR
    Crit Care Med; 2002 Jun; 30(6):1393-4. PubMed ID: 12072706
    [No Abstract]   [Full Text] [Related]  

  • 14. Nitric oxide, myocardial failure and septic shock.
    Brady AJ
    Int J Cardiol; 1995 Jul; 50(3):269-72. PubMed ID: 8537151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new therapeutic approach for the treatment of sepsis.
    Iskit AB; Guc MO
    Med Hypotheses; 2004; 62(3):342-5. PubMed ID: 14975500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overproduction of nitric oxide in pathophysiology of blood vessels.
    Stoclet JC; Muller B; Andriantsitohaina R; Kleschyov A
    Biochemistry (Mosc); 1998 Jul; 63(7):826-32. PubMed ID: 9721335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase inhibition as therapy for sepsis: a decade of promise.
    Cobb JP
    Surg Infect (Larchmt); 2001; 2(2):93-100; discussion 100-1. PubMed ID: 12594864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is use of nitric oxide (NO) synthase inhibitors justified for therapy of septic shock?].
    Jonderko G; Marcisz C; Braclik M
    Postepy Hig Med Dosw; 2003; 57(1):67-90. PubMed ID: 12765124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening.
    Xu C; Yi C; Wang H; Bruce IC; Xia Q
    Shock; 2012 Jan; 37(1):110-5. PubMed ID: 21993446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.